Intrexon Corp. (NYSE:XON)’s share price fell 2% on Tuesday . The stock traded as low as $29.20 and last traded at $29.25, with a volume of 756,307 shares changing hands. The stock had previously closed at $29.84.

Several research firms have weighed in on XON. Griffin Securities reaffirmed a “buy” rating and set a $55.00 target price on shares of Intrexon Corp. in a research note on Tuesday, August 16th. Zacks Investment Research cut Intrexon Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 12th. Vetr upgraded Intrexon Corp. from a “hold” rating to a “strong-buy” rating and set a $33.69 price target for the company in a report on Wednesday, August 3rd. JMP Securities reiterated a “buy” rating on shares of Intrexon Corp. in a report on Sunday, July 17th. Finally, Wunderlich reiterated a “buy” rating and set a $50.00 price target on shares of Intrexon Corp. in a report on Thursday, July 7th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Intrexon Corp. presently has an average rating of “Buy” and a consensus price target of $41.71.

The company’s market capitalization is $3.46 billion. The firm has a 50 day moving average of $26.53 and a 200-day moving average of $29.64.

Intrexon Corp. (NYSE:XON) last released its earnings results on Tuesday, August 9th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.16. The business earned $52.50 million during the quarter, compared to analysts’ expectations of $53.78 million. The company’s revenue for the quarter was up 17.0% on a year-over-year basis. During the same quarter last year, the firm earned ($0.37) earnings per share. Equities research analysts predict that Intrexon Corp. will post ($1.36) earnings per share for the current year.

A number of institutional investors recently added to or reduced their stakes in the stock. State of Wisconsin Investment Board raised its position in Intrexon Corp. by 2.5% in the fourth quarter. State of Wisconsin Investment Board now owns 35,410 shares of the company’s stock valued at $1,068,000 after buying an additional 880 shares during the last quarter. Bank of Montreal Can increased its stake in shares of Intrexon Corp. by 16.8% in the fourth quarter. Bank of Montreal Can now owns 40,010 shares of the company’s stock valued at $1,207,000 after buying an additional 5,742 shares during the period. Rhumbline Advisers increased its stake in shares of Intrexon Corp. by 6.7% in the fourth quarter. Rhumbline Advisers now owns 46,016 shares of the company’s stock valued at $1,387,000 after buying an additional 2,890 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Intrexon Corp. by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 141,851 shares of the company’s stock valued at $4,278,000 after buying an additional 4,854 shares during the period.

Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.